Department Food Engineering and Technology, Sao Paulo State University, Rua Cristóvão Colombo, 2265, Jardim Nazareth, São José Preto, SP, 15.0540-000, Brazil.
Faculty of Nutrition, Department of Food and Nutrition, UFMT - Mato Grosso Federal University, Cuiabá, MT, Brazil.
Probiotics Antimicrob Proteins. 2019 Jun;11(2):382-396. doi: 10.1007/s12602-018-9406-y.
The objective of this study was to evaluate the probiotic properties of Lactobacillus casei and Lactobacillus fermentum strains, as well as to select novel and safe strains for future development of functional fermented products. The in vitro auto-aggregation, co-aggregation, hydrophobicity, β-galactosidase production, survival to gastrointestinal tract (GIT), and antibiotic susceptibility were evaluated. The selected strains were additionally tested by the presence of genes encoding adhesion, aggregation and colonization, virulence factors, antibiotic resistance, and biogenic amine production, followed by the evaluation of acidifying kinetic parameters in milk, and survival of the strains under simulated GIT conditions during refrigerated storage of fermented milk. Most strains of both species showed high auto-aggregation; some strains showed co-aggregation ability with other lactic acid bacteria (LAB) and/or pathogens, and both species showed low hydrophobicity values. Seven L. casei and six L. fermentum strains produced β-galactosidase enzymes, and ten strains survived well the simulation of the GIT stressful conditions evaluated in vitro. All strains were resistant to vancomycin, and almost all the strains were resistant to kanamycin. L. casei SJRP38 and L. fermentum SJRP43 were distinguished among the other LAB strains by their higher probiotic potential. L. fermentum SJRP43 presented fewer genes related to virulence factors and antibiotic resistance and needed more time to reach the maximum acidification rate (V). The other kinetic parameters were similar. Both strains survived well (> 8 log CFU/mL) to the GIT-simulated conditions when incorporated in fermented milk. Therefore, these strains presented promising properties for further applications in fermented functional products.
本研究旨在评估干酪乳杆菌和发酵乳杆菌菌株的益生菌特性,并筛选出新型、安全的菌株,用于未来功能性发酵产品的开发。评估了这些菌株的体外自聚集、共聚、疏水性、β-半乳糖苷酶产生、胃肠道(GIT)生存能力和抗生素敏感性。选择的菌株还通过存在编码粘附、聚集和定植、毒力因子、抗生素耐药性和生物胺产生的基因进行了测试,然后评估了在牛奶酸化动力学参数和发酵乳冷藏储存过程中模拟 GIT 条件下菌株的生存能力。两种菌的大多数菌株都表现出较高的自聚集能力;一些菌株表现出与其他乳酸菌(LAB)和/或病原体的共聚能力,两种菌的疏水性值都较低。7 株干酪乳杆菌和 6 株发酵乳杆菌菌株产生β-半乳糖苷酶,10 株菌株在体外模拟 GIT 应激条件下生存良好。所有菌株均对万古霉素耐药,几乎所有菌株均对卡那霉素耐药。干酪乳杆菌 SJRP38 和发酵乳杆菌 SJRP43 与其他 LAB 菌株相比,具有更高的益生菌潜力。发酵乳杆菌 SJRP43 具有较少与毒力因子和抗生素耐药性相关的基因,且达到最大酸化速率(V)所需的时间更长。其他动力学参数相似。当这两种菌株被添加到发酵乳中时,都能很好地在模拟 GIT 条件下存活(>8 log CFU/mL)。因此,这些菌株具有在功能性发酵产品中进一步应用的良好特性。